Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy (Q39664977)

scientific article published on 19 August 2010

Language	Label	Description	Also known as
English	Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy	scientific article published on 19 August 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

13 September 2017

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

stated in

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy (English)

1 reference

stated in

Europe PubMed Central

13 September 2017

1 reference

Manasi Das

1

1 reference

stated in

Europe PubMed Central

PubMed ID

20727991

retrieved

13 September 2017

Sanjeeb K Sahoo

series ordinal

2

1 reference

stated in

Europe PubMed Central

13 September 2017

19 August 2010

1 reference

stated in

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

7

1 reference

stated in

Europe PubMed Central

13 September 2017

1

1 reference

stated in

Europe PubMed Central

13 September 2017

355-369

1 reference

stated in

Europe PubMed Central

13 September 2017

Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Mdm-2: "big brother" of p53.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Structure-based design of potent non-peptide MDM2 inhibitors

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Live or let die: the cell's response to p53

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

PUMA, a novel proapoptotic gene, is induced by p53

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Polymeric nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Nanotech approaches to drug delivery and imaging

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Molecular characterization of the hdm2-p53 interaction

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Apoptotic signaling by c-MYC.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Ligand-based targeted therapy for cancer tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

MDM2 inhibitors for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

p53 Activation by small molecules: application in oncology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Tumor suppressive functions of p53

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1).

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.ACTBIO.2010.08.010

Identifiers

DOI

10.1016/J.ACTBIO.2010.08.010

1 reference

stated in

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

PubMed ID

20727991

retrieved

13 September 2017

ResearchGate publication ID

242018982

0 references

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy (Q39664977)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy (Q39664977)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search